Researchers develop scalable method to generate key immune cells for cancer therapy

Researchers astatine the Center for Regenerative Medicine (CReM) astatine Boston Medical Center (BMC) and Boston University (BU) person developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding situation successful the improvement of stem cell-based immunotherapies. The findings, published successful Stem Cell Reports, could assistance beforehand efforts to make off-the-shelf CAR-T compartment therapies that tin beryllium produced astatine standard and made much readily disposable to patients.